Millipore and Applikon Collaborate on Disposable Bioreactors

Millipore Corporation (Billerica, MA) and Applikon Biotechnology BV (Schiedam, The Netherlands) have announced an agreement to co-develop and distribute disposable bioreactor systems for biopharmaceutical applications. The agreement will facilitate the companies’ joint entry into the disposable bioreactor segment of the disposables market.

Founded in 1973, Applikon Biotechnology designs, manufactures, and sells integrated bioreactor systems, and has significant expertise in the upstream bioprocessing market. By combining the experience of Applikon with Millipore’s Mobius suite of disposable technologies, the two companies will be able to offer biopharmaceutical customers a fully integrated disposable solution.

Disposable technologies help customers eliminate the need for cleaning validation and minimize water usage; reduce energy and labor costs; shorten cycle times between processing runs; and improve the flexibility of their operations. As biopharmaceutical companies increase protein expression and productivity in their upstream operations, the smaller scales of most disposable technologies are becoming a more viable alternative to classic stainless steel facilities.

Millipore release